Impaired anti-pneumococcal polysaccharide antibody production and invasive pneumococcal infection following heart transplantation

International Immunopharmacology

Volumn 6, Issue 13-14, 2006, Pages 2027-2030

  Sarmiento, E ^a   Rodriguez Hernandez C ^a   Rodriguez Molina J ^a   Fernandez Yanez J ^a   Palomo, J ^a   Anguita, J ^a   Perez J L ^b   Lanio, N ^a   Fernandez Cruz E ^a   Carbone, J ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Heart transplantation; Hypogammaglobulinemia; Immunosuppresion; Pneumococcal meningitis; Pneumococcal polysaccharide antibodies

Indexed keywords

ANTIBODY; CEFAZOLIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; CYTOMEGALOVIRUS ANTIBODY; DACLIZUMAB; FLUCONAZOLE; GANCICLOVIR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; ISONIAZID; ITRACONAZOLE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NORFLOXACIN; NYSTATIN; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS POLYSACCHARIDE ANTIBODY; PNEUMOCOCCUS VACCINE; PREDNISONE; RECOMBINANT HEPATITIS B VACCINE; TACROLIMUS; TETANUS TOXIN; VALGANCICLOVIR;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; ASPERGILLOSIS; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BACTERIAL PNEUMONIA; CLINICAL OBSERVATION; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEART TRANSPLANTATION; HEPATITIS B; HUMAN; HYPOGAMMAGLOBULINEMIA; IMMUNOLOGICAL MONITORING; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; NOCARDIOSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; URINARY TRACT INFECTION; VIRUS INFECTION;

ANTIBODY FORMATION; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED; MONITORING, IMMUNOLOGIC; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS; TRANSPLANTATION CONDITIONING; VACCINATION;

EID: 33845233544     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.09.011     Document Type: Article

References (8)

1. Amber I.J., Gilbert E.M., Schiffman G., and Jacobson J.A. Increased risk of pneumococcal infections in cardiac transplant recipients. Transplantation 49 (1990) 122-125
2. Duchini A., Goss J.A., Karpen S., and Pockros P.J. Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols. Clin Microbiol Rev 16 (2003) 357-364
3. Dengler T.J., Strnad N., Buhring I., Zimmermann R., Girgsdies O., Kubler W.E., et al. Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation. Transplantation 66 (1998) 1343-1346
4. Blumberg E.A., Brozena S.C., Stutman P., Wood D., Phan D.M., and Musher D.M. Immunogenicity of pneumococcal vaccine in heart transplant recipients. CID 32 (2001) 307-310
5. Gennery A.R., Cant A.J., Spickett G.P., Walshaw D., Hunter S., Hasan A., et al. Effect of immunosuppression after cardiac transplantation in early childhood on antibody response to polysaccharide antigen. Lancet 351 (1998) 1778-1781
6. Schauer U., Stemberg F., Rieger C.H.L., Büttner W., Borte M., Schubert S., et al. Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae Type b, and pneumococcal capsular polysaccharide in healthy children and adults. Clin Diagn Lab Immunol 10 (2003) 202-207
7. Shearer W.T., Buckley R.H., Engler R.J., Finn A.F., Fleisher T.A., Freeman T.M., et al. Practice parameters for the diagnosis and managements of immunodeficiency. Ann Allergy Asthma Immun 76 (1996) 282-294
8. Sarmiento E., Rodríguez-Molina J., Muñoz P., Fernández-Yánez J., Palomo J., Fogueda M., et al. Decreased levels of serum immunoglobulins as a risk factor of infection in heart transplantation. Transplant Proc 37 (2005) 4046-4049